Pacific Biosciences Of California reported $895.76M in Debt for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Debt Change
Accelerate Diagnostics AXDX:US 1.45M 147.99M
Agilent A:US $ 2858M 74M
Bruker BRKR:US $ 829.3M 5.1M
Danaher DHR:US $ 20423M 146M
Fluidigm FLDM:US $ 53.94M 0.11M
General Electric GE:US $ 63524M 7834M
Genmark Diagnostics GNMK:US $ 71.3M 0.55M
Illumina ILMN:US $ 1679M 481M
Luminex LMNX:US $ 253.51M 50.38M
Myriad Genetics MYGN:US $ 104.1M 49.9M
Nanostring Technologies NSTG:US $ 224.42M 0.35M
Oxford Immunotec Global OXFD:US $ 0M 0M
Pacific Biosciences Of California PACB:US $ 895.76M 0.09M
Perkinelmer PKI:US $ 2353.19M 224.91M
Quidel QDEL:US $ 0M 0M
Thermo Fisher Scientific TMO:US $ 18777M 132M
Waters WAT:US $ 1603.37M 99.72M